Filing Details

Accession Number:
0001209191-15-083803
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-07 17:31:43
Reporting Period:
2015-12-04
Filing Date:
2015-12-07
Accepted Time:
2015-12-07 17:31:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
906709 Nektar Therapeutics NKTR Pharmaceutical Preparations (2834) 943134940
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1229877 A Christopher Kuebler C/O Nektar Therapeutics
455 Mission Bay Boulevard Sout
San Francisco CA 94158
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-04 15,000 $5.15 35,000 No 4 M Direct
Common Stock Disposition 2015-12-04 15,000 $15.82 20,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2015-12-04 15,000 $0.00 15,000 $5.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-12-01 2016-12-01 No 4 M Direct
Footnotes
  1. This transaction involved a stock option scheduled to expire in 2016.